[Treatment of two cases of extramedullary infiltration multiple myeloma with BCMA CAR-T cells].

Sun, Y J; Liu, X C; Han, L; Wu, S S; Liu, Y Y; Gao, Q L; Song, Y P; Zhou, K S

Sun, Y J; Liu, X C; Han, L; Wu, S S; Liu, Y Y; Gao, Q L; Song, Y P; Zhou, K S.

Afiliação

Sun YJ; Department of Hematopathy, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Liu XC; Department of Hematopathy, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Han L; Department of Hematopathy, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Wu SS; Department of Hematopathy, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Liu YY; Department of Hematopathy, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Gao QL; Department of Hematopathy, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Song YP; Department of Hematopathy, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Zhou KS; Department of Hematopathy, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.

Zhonghua Xue Ye Xue Za Zhi ; 42(3): 253-255, 2021 03 14.

Article em Zh | MEDLINE | ID: mdl-33910313

Assuntos

Mieloma Múltiplo; Receptores de Antígenos Quiméricos; Antígeno de Maturação de Linfócitos B; Humanos; Imunoterapia Adotiva; Mieloma Múltiplo/terapia; Linfócitos T

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Mieloma Múltiplo Limite: Humans Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google